Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Gestational Trophoblastic Disease 2Trophoblastic Neoplasms 1Hydatidiform Mole 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Vacuum Curettage × Clear all
NCT04756713 2022-05-27

ReCure

Brigham and Women's Hospital

Phase 3 Unknown
150 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT00166790 2014-12-08

Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease

National Taiwan University Hospital

Unknown
30 enrolled
Gynecologic

Trophoblastic Neoplasms, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡